SAMMY LERMA: Open Payments
NPI 1871571950 · BASTROP, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$246 in 13 payments from 7 companies in 2025. Trend: 2023 $639 · 2024 $247 · 2025 $246
Food & beverage: $246
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 5 | $81 |
| Abbott Laboratories | 1 | $66 |
| ABBVIE INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Corium, LLC | 2 | $13 |
Products named: ZORYVE, PROCLAIM, VRAYLAR, TRELEGY ELLIPTA, CREON, TRINTELLIX, Dexcom G6 Transmitter, Azstarys.
Industry payments across TX — which companies pay providers there.
